amarogentin has been researched along with Liver Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, H; Wang, J; Zhang, Y | 1 |
| Banerjee, K; Das, A; Mandal, S; Pal, D; Panda, CK; Roy, A; Sur, S | 1 |
| Gong, J; Huang, C; Li, R; Zhang, Y | 1 |
3 other study(ies) available for amarogentin and Liver Neoplasms
| Article | Year |
|---|---|
Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.
Topics: AC133 Antigen; Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents, Phytogenic; Calcium-Binding Proteins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Hepatectomy; Human Umbilical Vein Endothelial Cells; Humans; Iridoids; Liver Neoplasms; Male; Mice; Neoplastic Stem Cells; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Radiofrequency Ablation; Receptor, Notch1; Signal Transduction; Tumor Burden; Tumor Suppressor Protein p53; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2020 |
Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model.
Topics: Animals; Carbon Tetrachloride; Cell Proliferation; Cell Survival; Female; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Hep G2 Cells; Humans; Hyaluronan Receptors; Iridoids; Liver Neoplasms; Mice; Neoplastic Stem Cells; Wnt Signaling Pathway | 2016 |
Amarogentin Induces Apoptosis of Liver Cancer Cells via Upregulation of p53 and Downregulation of Human Telomerase Reverse Transcriptase in Mice.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Iridoids; Liver Neoplasms; Male; Mice; Signal Transduction; Telomerase; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2017 |